These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 29513153)
1. Biomarkers identify the Binswanger type of vascular cognitive impairment. Barry Erhardt E; Pesko JC; Prestopnik J; Thompson J; Caprihan A; Rosenberg GA J Cereb Blood Flow Metab; 2019 Aug; 39(8):1602-1612. PubMed ID: 29513153 [TBL] [Abstract][Full Text] [Related]
2. Binswanger's disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia. Rosenberg GA J Neurochem; 2018 Mar; 144(5):634-643. PubMed ID: 28902409 [TBL] [Abstract][Full Text] [Related]
3. Validation of biomarkers in subcortical ischaemic vascular disease of the Binswanger type: approach to targeted treatment trials. Rosenberg GA; Prestopnik J; Adair JC; Huisa BN; Knoefel J; Caprihan A; Gasparovic C; Thompson J; Erhardt EB; Schrader R J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1324-30. PubMed ID: 25618903 [TBL] [Abstract][Full Text] [Related]
4. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD. Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198 [TBL] [Abstract][Full Text] [Related]
8. Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI. Hanyu H; Asano T; Tanaka Y; Iwamoto T; Takasaki M; Abe K Dement Geriatr Cogn Disord; 2002; 14(1):1-6. PubMed ID: 12053125 [TBL] [Abstract][Full Text] [Related]
9. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging]. Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239 [TBL] [Abstract][Full Text] [Related]
10. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067 [TBL] [Abstract][Full Text] [Related]
11. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease. Watanabe T; Shiino A; Akiguchi I Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735 [TBL] [Abstract][Full Text] [Related]